| | 51110-01-1 Basic information More.. |
| Product Name: | Somatostatin | | Synonyms: | panhibin;M.W. 1637.80 C76H104N18O19S2;CCRIS 3629;Somatostatin;Anti-Somatostatin, N-Terminal antibody produced in rabbit;SOMATOSTATIN [GIF];SOMATOSTATIN (HUMAN, OVINE, PORCINE, RAT, MOUSE);SOMATOSTATIN (HUMAN, OVINE, PORCINE, RAT, MOUSE) 2ACOH 6H2O | | CAS: | 51110-01-1 | | MF: | C76H104N18O19S2 | | MW: | 1637.88 | | EINECS: | 256-969-7 | | Mol File: | 51110-01-1.mol |  |
Use
Somatostatin was discovered in the hypothalamus. It is elaboratedby the δ-cells of the pancreas and elsewhere in thebody. Somatostatin is an oligopeptide (14 amino acidresidues) and is referred to as somatotropin release–inhibitingfactor (SRIF).Its primary action is inhibiting the release of GH from thepituitary gland. Somatostatin also suppresses the release ofboth insulin and glucagon. It causes a decrease in bothcAMP levels and adenylate cyclase activity. It also inhibitscalcium ion influx into the pituitary cells and suppressesglucose-induced pancreatic insulin secretion by activatingand deactivating potassium ion and calcium ion permeability,respectively. The chemistry, SARs, and potential clinicalapplications have been reviewed.
- Somatostatin
-
- $1.00
- 2026-11-02
- CAS:51110-01-1
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100kg
- Somatostatin
-
- 2026-11-02
- CAS:51110-01-1
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: 1000g
- Somatostatin Acetate
-
- 2026-10-26
- CAS:51110-01-1
- Min. Order: 1g
- Purity: >=99% (HPLC), USP43
- Supply Ability: 10000000g
|
|
51110-01-1
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
|